Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Baxter
McKinsey
McKesson
Johnson and Johnson
Express Scripts
Merck

Last Updated: December 1, 2021

DrugPatentWatch Database Preview

Litigation Details for Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)


Email this page to a colleague

« Back to Dashboard

Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)

Docket ⤷  Try it Free Date Filed 2020-08-21
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Maryellen Noreika
Jury Demand None Referred To
Parties DR. REDDY'S LABORATORIES, LTD.; LUPIN LIMITED
Patents 10,047,117; 10,052,337; 10,174,073; 7,138,390; 9,238,673
Attorneys Jeremy A. Tigan; Megan C. Haney
Firms Morris, Nichols, Arsht & Tunnell; Schiff Hardin LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Intercept Pharmaceuticals, Inc. v. Apotex Inc.
The small molecule drug covered by the patents cited in this case is ⤷  Try it Free .

Details for Intercept Pharmaceuticals, Inc. v. Apotex Inc. (D. Del. 2020)

Date Filed Document No. Description Snippet Link To Document
2020-11-12 15 Complaint - Amended expiration of U.S. Patent Nos. 9,238,673 (filed June 17, 2013) (“the ’673 patent”); 10,047,117 (filed Nov. …Notification of Certification for U.S. Patent Nos. 9,238,673; 10,047,117; 10,052,337; and 10,174,073 (NDA … ’073 patent”); 10,758,549 (filed Feb. 11, 2020) (“the ’549 patent”) (collectively the “patents-in-suit… 1. This action for patent infringement, brought pursuant to the patent laws of the United States…20, 2015) (“the ’117 patent”); 10,052,337 (filed Apr. 26, 2016) (“the ’337 patent”); 10,174,073 (filed External link to document
2020-11-12 16 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 9,238,673 B2; 10,047,117 B2; 10,052,… 21 August 2020 1:20-cv-01105 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2020-08-21 3 Patent/Trademark Report to Commissioner of Patents Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,238,673 B2 ;10,047,117 B2 ;10,052,… 21 August 2020 1:20-cv-01105 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
2021-03-03 35 Complaint - Amended 17, 2013) (“the ’673 patent”); 10,047,117 (filed Nov. 20, 2015) (“the ’117 patent”); 10,052,337 (filed…Notification of Certification for U.S. Patent Nos. 9,238,673; 10,047,117; 10,052,337; and 10,174,073 (NDA …’390 Patent”) prior to filing the Apotex ANDA. The RE286 Patent is a reissue of the ’390 Patent and, … 1. This action for patent infringement, brought pursuant to the patent laws of the United States… expiration of U.S. Patent Nos. RE48,286 (filed June 21, 2019) (“the RE286 Patent”); 9,238,673 (filed External link to document
2021-03-03 36 Patent/Trademark Report to Commissioner of Patents ,758,549; 9,238,673; 10,047,117; 10,052,337; 10,174,073. (Blumenfeld, Jack) Modified on 3/4/2021 (dlw)…AMENDED Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE48,286; 10,758,549… 21 August 2020 1:20-cv-01105 835 Patent - Abbreviated New Drug Application(ANDA) None External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKesson
Harvard Business School
Moodys
Medtronic
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.